A phase I study comparing the pharmacokinetics of the biosimilar (RD12014) with liraglutide (Victoza) in healthy Chinese male subjects
Abstract This study aimed to evaluate the pharmacokinetics (PKs), safety, and immunogenicity of the biosimilar (RD12014) compared to reference liraglutide (Victoza) in healthy Chinese male subjects, so as to provide the basis for the similarity evaluation of the two drugs. Eligible subjects were ran...
Saved in:
Main Authors: | Ruirui Zhou (Author), Linfeng Guo (Author), Xianglei Gao (Author), Yijun Wang (Author), Wenjing Xu (Author), Yang Zou (Author), Wenjia Li (Author), Yulei Zhuang (Author), Gangyi Liu (Author), Yanmei Liu (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2022-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A Randomized Phase 1 Pharmacokinetic Study Comparing the Potential Biosimilar LRG201902 With Liraglutide (Victoza®) in Healthy Male Subjects
by: Gang Mai, et al.
Published: (2021) -
Evaluating the bioequivalence and safety of liraglutide injection versus Victoza® in healthy Chinese subjects: a randomized, open, two-cycle, self-crossover phase I clinical trial
by: Chao Liu, et al.
Published: (2023) -
A pharmacokinetic study comparing the biosimilar HEC14028 and Dulaglutide (Trulicity®) in healthy Chinese subjects
by: Xianglei Gao, et al.
Published: (2024) -
MB09, a denosumab biosimilar candidate: Biosimilarity demonstration in a phase I study in healthy subjects
by: Monika Tomaszewska‐Kiecana, et al.
Published: (2024) -
A Phase I, Randomized, Single-Dose Study Evaluating the Biosimilarity of TAB008 to Bevacizumab in Healthy Volunteers
by: Jin Wang, et al.
Published: (2019)